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study, the degree of hypothermia during CPB should also 
be considered a factor influencing the production of 
IL-10. 
For all the reasons discussed herein, the release of the 
antiinflammatory c tokine IL-10 in response to the in- 
flammatory stress of CPB is a process largely dependent 
on the immunomodulatory effect of the inflammatory, 
pharmacologic, and physical variables that are related to 
the protocol adopted for cardiac operations. 
Marie-Christine Seghaye, MD 
Department of Pediatric Cardiology 
RWTH Aachen 
Pauwelsstrasse 30
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Atrial natriuretie peptide release after cardiac 
transplantation 
To the Editor: 
We read with interest the article "Atrial Natriuretic 
Peptide Release at Rest and With Exercise After Cardiac 
Transplantation With the Bicaval Technique" by Jahnke 
and associates (J Thorac Cardiovas Surg 1995;110:1600- 
5). We have been interested in the significance of the high 
levels of natriuretic peptides released after cardiac trans- 
plantation. Our findings, 1presented before the New York 
meeting of The International Society for Heart and Lung 
Transplantation i  March 1996, correlate in some aspects 
with the findings of Jahnke and his associates. 
High levels of plasma atrial natriuretic peptide (ANP) 
and ventricular expression of brain natriuretic peptide 
(BNP) have been identified after standard orthotopic 
cardiac transplantation. 2-4It was postulated that the large 
atrial mass after transplantation maintains the secretion of 
the high levels of ANP. 5 The significance of high levels of 
BNP after cardiac transplantation is unknown. 4 We have 
studied 40 ambulatory, randomly selected patients 6 
months to 1 year after cardiac transplantation. Plasma 
levels of both ANP and BNP were elevated in patients 
who had bicaval orthotopic heart transplantation with 
small atrial mass (ANP, 197.9 _+ 30.22 pg/ml; BNP, 7.4 _+ 
7.1 pg/ml [mean ± standard eviation]) and in patients 
who had standard orthotopic heart transplantation and 
large atrial mass (ANP, 191.3 _+ 44.6.88 pg/ml; BNP, 
10.9 ± 7.6 pg/ml) in comparison with normal healthy 
volunteers (ANP, 95.7 +- 30.1 pg/ml; BNP, 1.18 _+ 0.18; 
p < 0.0001 andp < 0.0001, respectively ). ANP levels were 
not significantly different between the bicaval and the 
standard group. These data suggest hat high levels of 
ANP were synthesized and secreted by the transplanted 
denervated human heart, regardless of the transplantation 
technique. Despite the near complete denervation with 
the bicaval technique, ANP secretion continued, support- 
ing the findings of Jahnke and colleagues. Lower mean 
systemic pressure and high serum urea content are asso- 
ciated with higher levels of ANP (p < 0.05), which can be 
the result of the vasodilator potential of ANP. BNP levels 
were significantly higher in the standard group (10.9 -+ 7.6 
pg/ml) than in the bicaval group (7.4 _+ 7.1 pg/ml; p = 
0.01). Patients in the standard group had a higher mean 
pulmonary artery pressure, right ventricular systolic pres- 
sure, and transpulmonary gradient. Linear regression 
analysis howed that faster heart rate, high mean pulmo- 
nary artery pressure, high pulmonary capillary wedge 
pressure, high transpulmonary gradient and higher cyclo- 
sporine trough levels are associated with higher levels of 
BNP (p < 0.05). We found higher levels of BNP in the 
standard group than in the bicaval group. The increased 
BNP was associated with an increase in the right ventric- 
ular afterload, manifested by a raised transpulmonary 
gradient and raised pulmonary capillary wedge pressure 
without overt ventricular failure. We have demonstrated a 
positive correlation between the BNP levels and heart 
rate, which we suppose is another marker for ventricular 
strain. Our findings correlate well with current under- 
standing of BNP physiology. Plasma levels of BNP mainly 
reflect the degree of ventricular afterload. 6 
There was no correlation between left ventricular sys- 
tolic function (echo recorded ejection fraction) and BNP. 
We can assume that BNP levels after transplantation 
reflect predominantly right ventricular and left ventricular 
diastolic function. There was a positive correlation be- 
tween the BNP and trough cyclosporine l vels. Cyclospo- 
rine therapy tends to increase sympathetic activity, and 
this may contribute to posttransplantation pulmonary and 
systemic hypertension i creasing the afterload. Another 
contributor is salt and water retention caused by stimula- 
tion of the renin-angiotensin-aldosterone syst m. It seems 
that the increased production of natriuretic peptides is a 
normal physiologic response to the hypertension and 
increased water and salt retention. Right atrial pressure, 
ejection fraction, serum creatinine, serum electrolytes, 
and the histologic grade of rejection did not show signif- 
icant correlation with raised ANP and BNP after either 
technique of orthotopic heart transplantation. Unlike 
Jahnke and colleagues, we found no correlation between 
cold ischemic time and the release of natriuretic peptides. 
In summary, there is no correlation between atriuretic 
peptide secretion and atrial mass or renal function. Dif- 
ferential regulation of ANP and BNP seems to influence 
the secretion of both hormones after transplantation. 
BNP correlates predominantly with right ventricular per- 
formance and afterload. The bicaval technique seems to 
be associated with better right ventricular performance. 
The ANP vasodilator effect may be a compensatory 
mechanism to the cyclosporine hypertensiv e effect. Mea- 
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suring natriuretic peptide levels in other solid organ 
transplantation may identify the cause and effect relation- 
ship between cyclosporine therapy and hypertension-re- 
lated diastolic dysfunction. 
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Reply to the Editoi:" 
In the stage of ventricular overload and especially 
failure, the secretion of natriuretic peptides (atrial natri- 
uretic peptide, ANP, and brain natriuretic peptide, BNP) 
is increased with compensatory, beneficial effects like 
enhanced iuresis, natriuresis, and inhibition of the renin- 
angiotensin system and the sympathetic nervous ystem. ~
ANP is predominantly released from atrial tissue stimu- 
lated by elevated wall stress. Theoretically, the bicaval 
technique in cardiac transplantation with significantly 
lower atrial dimensions and pressures 2 and thus wall stress 
should result in a decrease of the high level of ANP after 
standard cardiac transplantation. However, we could not 
measure a significant difference in the ANP levels be- 
tween the two transplantation techniques, an experience 
that was confirmed by EL Gamel and associates. Thus 
other mechanisms probably cause these high ANP levels. 
Whether one of these mechanisms i  related to primary or 
secondary effects of cyclosporine medication, as stated by 
EL Gamel's group, remains to be established. We could 
not find a correlation between the ANP and the cyclospo- 
rine trough level (r = -0.1164,p = 0.3828, n = 9). Other 
possible explantations for increased ANP levels are the 
denervation of the transplanted heart and a hypersensi- 
tivity of ANP-synthesizing cells to circulating cat- 
echolamines. 3 
EL Gamel and coworkers hould be congratulated for 
extending the knowledge of heart transplantation biology 
inasmuch as they found that the BNP level was signifi- 
cantly higher in the standard transplantation group, re- 
flecting a physiologic response to increased ventricular 
afterload. This represents a further argument in favor of 
the bicaval technique in cardiac transplantation. These 
new findings raise new questions: Are the drastically 
increased ANP levels after cardiac transplantation still 
beneficial? Are reinnervation procedures effective to op- 
timize regulation of ANP response? Does BNP level in 
patients after transplantation provide any prognostic in- 
formation comparable with patients after myocardial in- 
farction? 4 Is intravenous BNP valuable to improve post- 
operative hemodynamics? Is there any relation between 
the change of peptide levels and evolving rejection? We 
look forward with great interest o further progress in 
research in this context. 
Hans H. Sievers, MD 
Klinik fitr Herzchirurgie 
Medizinische Universitiit Liibeck 
Liibeck, Ge~7"nany 
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